{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T07:40:19Z","timestamp":1707550819378},"reference-count":32,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:p>Com objetivo de avaliar a influ\u00eancia das drogas antitiroidianas (AT) sobre a efic\u00e1cia da dose terap\u00eautica de iodo radioativo (DT), avaliamos retrospectivamente 226 prontu\u00e1rios de pacientes portadores de doen\u00e7a de Graves submetidos \u00e0 DT no per\u00edodo entre 1990 e 2001: 58 pacientes sem antitiroidiano (AT), 119 em uso de propiltiouracil (PTU) e 49 em uso de metimazol (MMI). O estado funcional tiroidiano 9-12 meses p\u00f3s-DT dividia os pacientes entre curados e n\u00e3o curados. N\u00edveis elevados de T4 livre, capta\u00e7\u00e3o de 131I em 24 h tiveram influ\u00eancia negativa sobre a taxa de cura, assim como menor dose de iodo administrada e maior volume do b\u00f3cio (p&lt; 0,05). O percentual de pacientes curados em uso de PTU previamente \u00e0 DT foi de 70,2% (84\/119), enquanto nos pacientes em uso de MMI foi de 85,7% (42\/49), e de 84,5% (49\/58) nos pacientes sem AT pr\u00e9-DT (p= 0,034). Em modelo de regress\u00e3o multivariado, T4 livre &gt; 4 ng\/dl, maior volume do b\u00f3cio, dose terap\u00eautica &lt; 10 mCi e o uso pr\u00e9vio de PTU tiveram rela\u00e7\u00e3o com menores taxas de cura. Quando comparado ao grupo sem AT, conclu\u00edmos que PTU implica em maior risco de fal\u00eancia p\u00f3s-DT (OR= 3,13), o mesmo n\u00e3o ocorrendo com MMI (OR= 1,28).<\/jats:p>","DOI":"10.1590\/s0004-27302006000600016","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T16:49:50Z","timestamp":1169052590000},"page":"1088-1095","source":"Crossref","is-referenced-by-count":1,"title":["Efeito do propiltiouracil sobre a efic\u00e1cia da dose terap\u00eautica de iodo radioativo (I-131) no hipertiroidismo por doen\u00e7a de graves"],"prefix":"10.1590","volume":"50","author":[{"given":"Marcus V.L. de","family":"Souza","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Buescu","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Vaisman","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honomar F. de","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronir Raggio","family":"Luiz","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0001-2998(96)80020-1","article-title":"Radioiodine and thyroid disease: The beginning","volume":"26","author":"Becker DV","year":"1996","journal-title":"Sem Nucl M\u00e9d"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/thy.1997.7.163","article-title":"Radioiodine and the treatment of hyperthyroidism: The early history","volume":"7","author":"Sawin CT","year":"1997","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.1997.7.225","article-title":"Case selection and restrictions recommended to patients with hyperthyroidism in South America","volume":"7","author":"Romaldini JH","year":"1997","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1590\/S0004-27302001000600009","article-title":"Inqu\u00e9rito sobre o uso de 131I no Brasil","volume":"45","author":"Albino CC","year":"2001","journal-title":"Arq Bras Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1470001","article-title":"Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goiters","volume":"147","author":"Bonnema SJ","year":"2002","journal-title":"Eur J Endocrinol","ISSN":"http:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves\u2019 disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti P","year":"1997","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1210\/jcem-70-3-675","article-title":"Antithyroid drugs and Graves\u2019 disease: a prospective randomized evaluation of the efficacy of treatment duration","volume":"70","author":"Allannic H","year":"1990","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.1989.tb01244.x","article-title":"Antithyroid drugs in the treatment of hyperthyroidism of Graves\u2019 disease: long term follow-up of 434 patients","volume":"31","author":"Hedley AJ","year":"1989","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref9","first-page":"51","article-title":"Hyperthyroidism in the land of Graves\u2019 disease: results of treatment by surgery, radioiodine, and carbimazole in 837 cases","volume":"49","author":"Sugrue D","year":"1980","journal-title":"Q J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0033-5622","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-92-4-488","article-title":"Thionamide therapy in Graves\u2019 disease: relation of relapse rate to duration of therapy","volume":"92","author":"Tamai H","year":"1980","journal-title":"Ann Int Med"},{"key":"ref11","series-title":"Werner and Ingbar\u2019s The Thyroid: A fundamental and clinical text","first-page":"691","volume-title":"Treatment of thyrotoxicosis","author":"Cooper DS","year":"2000","edition":"8th"},{"key":"ref12","first-page":"3611","article-title":"Radioiodine treatment of hyperthyroidism: prognostic factors for outcome","volume":"86","author":"Allahabadia A","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref13","first-page":"2986","article-title":"Graves\u2019 hyperthyroidism: treatment with antithyroid drugs, surgery or radioiodine - a prospective randomized study","volume":"81","author":"Torring O","year":"1996","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0950-351X(97)80798-7","article-title":"Treatment of Graves disease: the American way","volume":"11","author":"Levy EG","year":"1997","journal-title":"Bailli\u00e8re\u2019s Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0889-8529(05)70307-8","article-title":"Treatment of hyperthyroidism with radioactive iodine","volume":"27","author":"Kaplan MM","year":"1998","journal-title":"Endocr Metab Clin North Am"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jcem.83.2.4538","article-title":"Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism","volume":"83","author":"Imseis RE","year":"1998","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref17","first-page":"3488","article-title":"The effect of methimazole pretreatment on the efficacy of radioactive Iodine therapy in Graves\u2019 hyperthyroidism: One-year follow-up of a prospective, randomized study","volume":"86","author":"Andrade VA","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/thy.1995.5.243","article-title":"Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves\u2019 disease","volume":"5","author":"Tuttle RM","year":"1995","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/1050725041517093","article-title":"Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves\u2019 disease","volume":"14","author":"Santos RB","year":"2004","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1210\/jc.2004-0247","article-title":"Propylthiouracil before 131I therapy of hyperthyroidism diseases: Effect on cure rate evaluated by a randomized trial","volume":"89","author":"onnema SJ","year":"2004","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref21","first-page":"411","article-title":"Optimal iodine-131 dose for eliminating hyperthyroidism in Graves\u2019 disease","volume":"32","author":"Nordyke RA","year":"1991","journal-title":"J Nucl Med","ISSN":"http:\/\/id.crossref.org\/issn\/0161-5505","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM197401172900306","article-title":"Low dose 131I therapy of thyrotoxicosis (diffuse goiter)","volume":"290","author":"Cevallos JL","year":"1974","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.0954-6820.1985.tb01634.x","article-title":"Treatment of hyperthyroidism with Standard doses of radioiodine aiming at ablation","volume":"214","author":"Eriksson E","year":"1985","journal-title":"Acta Med Scand","ISSN":"http:\/\/id.crossref.org\/issn\/0001-6101","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archinte.1975.00330050047007","article-title":"Treatment of hyperthyroidism with a large initial dose of sodium iodide 131I","volume":"135","author":"Safa AM","year":"1975","journal-title":"Arch Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03164966","article-title":"Long-term follow-up studies on iodine-131 treatment of hyperthyroid Graves\u2019 disease based on the measurement of thyroid gland volume by ultrasonography","volume":"7","author":"Tsuruta M","year":"1993","journal-title":"Ann Nucl Med","ISSN":"http:\/\/id.crossref.org\/issn\/0914-7187","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM198408163110702","article-title":"Long-term follow-up study of compensated low-dose 131I therapy for Graves\u2019 disease","volume":"311","author":"Sridama V","year":"1984","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1210\/jc.2003-030185","article-title":"Antithyroid drugs in the management of patients with Graves\u2019 disease: An evidence-based approach to therapeutic controversies","volume":"88","author":"Cooper DS","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref28","first-page":"1229","article-title":"Success rate of radioiodine therapy in Graves\u2019 disease: The influence of thyrostatic medication","volume":"84","author":"Sabri O","year":"1999","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref29","first-page":"387","article-title":"Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole","volume":"34","author":"Clerc J","year":"1993","journal-title":"J Nucl Med","ISSN":"http:\/\/id.crossref.org\/issn\/0161-5505","issn-type":"print"},{"key":"ref30","first-page":"4012","article-title":"Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves\u2019 hyperthyroidism","volume":"84","author":"Andrade VA","year":"1999","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00007611-199508000-00007","article-title":"Thionamides alter the efficacy of radioiodine treatment in patients with Graves\u2019 disease","volume":"88","author":"Koroscil TM","year":"1995","journal-title":"South Med J","ISSN":"http:\/\/id.crossref.org\/issn\/0038-4348","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2265.1997.2741075.x","article-title":"The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves\u2019 disease","volume":"47","author":"Hancock LD","year":"1997","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v50n6\/a16v50n6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T07:19:23Z","timestamp":1707549563000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302006000600016&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0004-27302006000600016"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302006000600016","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}